Los Angeles, CA – In a significant development stemming from the tragic death of beloved actor Matthew Perry, Jasveen Sangha, widely known as the "Ketamine Queen" for her illicit drug distribution network, was sentenced to 15 years in federal prison on Wednesday morning, April 8, 2026. The sentencing, handed down in a Los Angeles courthouse, marks a pivotal moment in the legal fallout surrounding Perry’s passing, which was officially attributed to the "acute effects of ketamine." Sangha’s conviction includes a critical charge of distributing ketamine resulting in death, directly linking her criminal activities to the fatal overdose of the Friends star.
Details of the Sentencing and Charges
Jasveen Sangha’s journey to a federal prison sentence began with her prominence in the North Hollywood drug trade, where she was known for her extensive dealings in ketamine. Following a comprehensive investigation into the circumstances of Matthew Perry’s death, Sangha was apprehended in August 2024. Last year, she entered a guilty plea to a total of five federal criminal charges. These charges encompassed three counts of ketamine distribution, one count of distributing ketamine resulting in death—the most severe charge directly connecting her to Perry’s demise—and one count of maintaining a drug-involved premises.
The sentencing hearing revealed the gravity of the offenses. While Sangha faced a potential maximum sentence of up to 65 years in prison, federal prosecutors ultimately recommended the 15-year term that was imposed by the judge. This recommendation, though significantly less than the statutory maximum, reflected a balance between securing a conviction for the death-related charge and acknowledging the complexities of the plea agreement. Sangha’s legal defense team had advocated for a more lenient sentence, requesting "time served," given that she had been incarcerated since her arrest in August 2024. The judge, however, opted for the prosecution’s recommendation, underscoring the serious nature of distributing controlled substances, particularly when they lead to a fatality.
The Tragic Passing of Matthew Perry
The catalyst for this extensive investigation and subsequent prosecutions was the untimely death of Matthew Perry on October 28, 2023. The actor, globally recognized for his iconic role as Chandler Bing on the hit sitcom Friends, was found unresponsive in his hot tub at his Pacific Palisades home. His passing sent shockwaves through Hollywood and among millions of fans worldwide, many of whom had followed his public struggles with addiction over the years.
The Los Angeles County Medical Examiner-Coroner’s report later confirmed that Perry’s death was accidental, primarily caused by the "acute effects of ketamine." Contributing factors included drowning, coronary artery disease, and the effects of buprenorphine, a medication often used to treat opioid addiction. The toxicology report indicated exceptionally high levels of ketamine in Perry’s system, far exceeding what would typically be found in a therapeutic setting. This crucial finding initiated a rigorous multi-agency investigation, involving local law enforcement and federal agencies, to trace the source of the illicit ketamine that led to his death.
Perry had openly discussed his battles with substance abuse throughout his life, detailing them in his memoir, "Friends, Lovers, and the Big Terrible Thing." His candidness brought a human face to the complexities of addiction, making his death a poignant reminder of the pervasive challenges many face. The discovery that his death involved ketamine, a substance with both legitimate medical uses and high potential for abuse, further highlighted the dangers of illicit drug procurement.
The Investigation Unfolds: A Chronology of Accountability
The investigation into Matthew Perry’s death was multifaceted, extending beyond the immediate circumstances of his passing to uncover the network supplying the fatal dose.
- October 28, 2023: Matthew Perry is found dead. The initial coroner’s report points to acute ketamine effects.
- November 2023 – Summer 2024: Law enforcement agencies, including the LAPD and DEA, launch a joint investigation. This phase involves extensive forensic analysis, interviews, and digital forensics to trace the origin of the ketamine found in Perry’s system. The focus quickly turned to individuals involved in the illicit distribution of the drug.
- August 2024: Jasveen Sangha, identified as a key figure in the illicit ketamine trade in the North Hollywood area, is arrested. Her arrest marks a significant breakthrough in the case.
- Last Year (Specific Date Not Provided, but presumably late 2024 or early 2025): Jasveen Sangha pleads guilty to five federal charges, including distribution of ketamine resulting in death. This plea is crucial as it avoids a lengthy trial and secures a conviction directly related to Perry’s death.
- December 3, 2025: Dr. Salvador Plasencia, another individual implicated in the illicit distribution of ketamine, is sentenced to 30 months in prison after pleading guilty to four counts of distribution of ketamine. His involvement highlights how prescription drugs can be diverted into illicit channels.
- December 16, 2025: Perry’s assistant, Kenneth Iwasama, and another dealer, Erik Fleming, plead guilty to their respective charges in connection with the case. Their sentencing dates are set for later this month.
- April 8, 2026: Jasveen Sangha is sentenced to 15 years in federal prison.
This timeline illustrates the methodical approach taken by authorities to dismantle the supply chain responsible for Perry’s death, emphasizing that all involved parties, from street dealers to medical professionals, face legal repercussions.
The Broader Impact and Implications
The sentencing of Jasveen Sangha serves as a stern message to those involved in the illicit drug trade, particularly when their actions lead to fatal consequences. The "distributing ketamine resulting in death" charge carries significant weight under federal law, reflecting society’s increasing intolerance for drug-related fatalities. This case underscores the serious legal risks associated with unregulated drug distribution, irrespective of the substance.
Ketamine, while recognized for its anesthetic properties and increasingly for its potential in treating severe depression and PTSD in controlled medical settings, remains a Schedule III controlled substance. Its diversion from legitimate medical channels for recreational use carries substantial health risks, including overdose, psychological effects, and potential for abuse and dependence. The high profile of Matthew Perry’s death has inadvertently shone a spotlight on the dangers of illicit ketamine use, prompting greater public awareness and reinforcing the need for stringent regulatory oversight.
The involvement of a medical professional, Dr. Salvador Plasencia, further complicates the narrative, highlighting the potential for abuse within legitimate systems. His 30-month sentence, while less than Sangha’s, underscores the legal ramifications for healthcare providers who misuse their privileges to contribute to the drug trade. The pleas of Perry’s assistant, Kenneth Iwasama, and dealer Erik Fleming, indicate a wider network of individuals who facilitated the actor’s access to controlled substances, illustrating the pervasive nature of addiction and the support systems, albeit illicit, that can form around individuals struggling with substance use disorders.
This case also brings into focus the challenges faced by law enforcement in combating drug distribution networks. The resources dedicated to investigating Perry’s death reflect a commitment to pursuing justice even in complex cases involving high-profile individuals and multiple layers of distribution. The outcome of these legal proceedings will likely influence future prosecutorial strategies in drug-related fatalities, setting a precedent for holding distributors accountable for the ultimate consequences of their illicit activities.
Official Responses and Legal Perspectives
While no direct statements from prosecutors or defense attorneys were provided in the initial reports beyond their sentencing recommendations, their positions are clear through their actions. Prosecutors, by requesting a 15-year sentence, indicated their pursuit of substantial justice for the role Sangha played in Perry’s death, balancing the maximum potential penalty with the practicalities of securing a guilty plea. Their emphasis would undoubtedly be on public safety and deterrence, aiming to send a clear message that such actions will not be tolerated.
The defense, in seeking "time served," would have argued for leniency based on Sangha’s cooperation, potential remorse, or the duration of her pre-sentencing incarceration. Such arguments are standard in criminal proceedings, aiming to mitigate the severity of the punishment by highlighting factors that might persuade the judge towards a shorter term. However, the federal judge’s decision to align with the prosecution’s recommendation suggests the court weighed the serious nature of the "distributing ketamine resulting in death" charge heavily.
This case has resonated within legal circles as well, serving as a powerful example of how federal agencies pursue drug cases, particularly when a celebrity death brings heightened public and media scrutiny. The detailed investigation and the successful prosecution of multiple individuals involved in the supply chain demonstrate the effectiveness of collaborative law enforcement efforts in dismantling illicit drug operations.
The sentencing of Jasveen Sangha to 15 years in federal prison marks a significant conclusion to a chapter in the tragic aftermath of Matthew Perry’s death. It serves as a stark reminder of the devastating consequences of illicit drug distribution and the relentless pursuit of justice by law enforcement. As the remaining individuals, Kenneth Iwasama and Erik Fleming, await their sentencing later this month, the legal system continues its work to hold all accountable for their roles in a case that deeply impacted millions.
